Pd Rx Pharmaceutical Stock Market Value
| PDRX Stock | USD 2.90 0.00 0.00% |
| Symbol | Pd-Rx |
Pd-Rx Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pd-Rx Pharmaceutical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pd-Rx Pharmaceutical.
| 06/09/2024 |
| 12/31/2025 |
If you would invest 0.00 in Pd-Rx Pharmaceutical on June 9, 2024 and sell it all today you would earn a total of 0.00 from holding Pd Rx Pharmaceutical or generate 0.0% return on investment in Pd-Rx Pharmaceutical over 570 days. Pd-Rx Pharmaceutical is related to or competes with Sweet Earth, and Interpace Biosciences. PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the h... More
Pd-Rx Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pd-Rx Pharmaceutical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pd Rx Pharmaceutical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 8.9 |
Pd-Rx Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pd-Rx Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pd-Rx Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Pd-Rx Pharmaceutical historical prices to predict the future Pd-Rx Pharmaceutical's volatility.| Risk Adjusted Performance | 0.0252 | |||
| Jensen Alpha | 0.0117 | |||
| Total Risk Alpha | (0.06) | |||
| Treynor Ratio | 0.1379 |
Pd Rx Pharmaceutical Backtested Returns
At this stage we consider Pd-Rx Pink Sheet to be somewhat reliable. Pd Rx Pharmaceutical retains Efficiency (Sharpe Ratio) of 0.0328, which implies the firm had a 0.0328 % return per unit of price deviation over the last 3 months. We have found seventeen technical indicators for Pd-Rx Pharmaceutical, which you can use to evaluate the volatility of the company. Please check Pd-Rx Pharmaceutical's market risk adjusted performance of 0.1479, and Information Ratio of (0.04) to confirm if the risk estimate we provide is consistent with the expected return of 0.0323%. Pd-Rx Pharmaceutical has a performance score of 2 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of 0.15, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pd-Rx Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pd-Rx Pharmaceutical is expected to be smaller as well. Pd Rx Pharmaceutical at this time owns a risk of 0.99%. Please check Pd Rx Pharmaceutical risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and day median price , to decide if Pd Rx Pharmaceutical will be following its current price history.
Auto-correlation | -0.45 |
Modest reverse predictability
Pd Rx Pharmaceutical has modest reverse predictability. Overlapping area represents the amount of predictability between Pd-Rx Pharmaceutical time series from 9th of June 2024 to 21st of March 2025 and 21st of March 2025 to 31st of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pd Rx Pharmaceutical price movement. The serial correlation of -0.45 indicates that just about 45.0% of current Pd-Rx Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.45 | |
| Spearman Rank Test | -0.42 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Pd Rx Pharmaceutical lagged returns against current returns
Autocorrelation, which is Pd-Rx Pharmaceutical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pd-Rx Pharmaceutical's pink sheet expected returns. We can calculate the autocorrelation of Pd-Rx Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Pd-Rx Pharmaceutical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pd-Rx Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pd-Rx Pharmaceutical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pd-Rx Pharmaceutical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pd-Rx Pharmaceutical pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Pd-Rx Pharmaceutical Lagged Returns
When evaluating Pd-Rx Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pd-Rx Pharmaceutical pink sheet have on its future price. Pd-Rx Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pd-Rx Pharmaceutical autocorrelation shows the relationship between Pd-Rx Pharmaceutical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Pd Rx Pharmaceutical.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pd-Rx Pink Sheet Analysis
When running Pd-Rx Pharmaceutical's price analysis, check to measure Pd-Rx Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pd-Rx Pharmaceutical is operating at the current time. Most of Pd-Rx Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Pd-Rx Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pd-Rx Pharmaceutical's price. Additionally, you may evaluate how the addition of Pd-Rx Pharmaceutical to your portfolios can decrease your overall portfolio volatility.